| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
ABC transporters in Leishmania and their role in drug resistance
|
Ouellette, Marc
|
|
1998
|
|
1 |
p. 43-48
6 p.
|
artikel
|
| 2 |
Activation and role of caspases in chemotherapy-induced apoptosis
|
Schmitt, Estelle
|
|
1999
|
|
1 |
p. 21-29
9 p.
|
artikel
|
| 3 |
Antifungal resistance in non- albicans Candida species
|
Collin, Berjan
|
|
1999
|
|
1 |
p. 9-14
6 p.
|
artikel
|
| 4 |
Antifungal susceptibility testing of yeasts: uses and limitations
|
Reyes, Guadalupe
|
|
2000
|
|
1 |
p. 14-19
6 p.
|
artikel
|
| 5 |
Antiviral drug resistance and helicase–primase inhibitors of herpes simplex virus
|
Field, Hugh J.
|
|
2011
|
|
1 |
p. 45-51
7 p.
|
artikel
|
| 6 |
Apoptosis induction by arsenic: mechanisms of action and possible clinical applications for treating therapy-resistant cancers
|
Bode, Ann
|
|
2000
|
|
1 |
p. 21-29
9 p.
|
artikel
|
| 7 |
Apoptosis pathways: turned on their heads?
|
Fulda, Simone
|
|
2003
|
|
1 |
p. 1-3
3 p.
|
artikel
|
| 8 |
Biochemical mechanisms involved in overcoming HIV resistance to nucleoside inhibitors of reverse transcriptase
|
Götte, Matthias
|
|
2000
|
|
1 |
p. 30-38
9 p.
|
artikel
|
| 9 |
Causes of drug resistance and novel therapeutic opportunities for the treatment of glioblastoma
|
Nagane, Motoo
|
|
1999
|
|
1 |
p. 30-37
8 p.
|
artikel
|
| 10 |
Creeping baselines and adaptive resistance to antibiotics
|
Fernández, Lucía
|
|
2011
|
|
1 |
p. 1-21
21 p.
|
artikel
|
| 11 |
Cryptosporidiosis and the challenges of chemotherapy
|
Mead, Jan R.
|
|
2002
|
|
1 |
p. 47-57
11 p.
|
artikel
|
| 12 |
Determinants of resistance to 2′,2′-difluorodeoxycytidine (gemcitabine)
|
Bergman, Andries M
|
|
2002
|
|
1 |
p. 19-33
15 p.
|
artikel
|
| 13 |
Drug transporters of platinum-based anticancer agents and their clinical significance
|
Burger, Herman
|
|
2011
|
|
1 |
p. 22-34
13 p.
|
artikel
|
| 14 |
3D structure of AcrB: the archetypal multidrug efflux transporter of Escherichia coli likely captures substrates from periplasm
|
Elkins, Christopher A.
|
|
2003
|
|
1 |
p. 9-13
5 p.
|
artikel
|
| 15 |
Editorial
|
Georgopapadakou, Nafsika
|
|
2002
|
|
1 |
p. 1-
1 p.
|
artikel
|
| 16 |
EDITORIAL
|
Georgopapadakou, Nafsika
|
|
2001
|
|
1 |
p. 1-2
2 p.
|
artikel
|
| 17 |
Editorial
|
Georgopapadakou, Nafsika H.
|
|
1998
|
|
1 |
p. 1-
1 p.
|
artikel
|
| 18 |
EDITORIAL
|
Georgopapadakou, Nafsika H.
|
|
1999
|
|
1 |
p. 1-
1 p.
|
artikel
|
| 19 |
Editorial
|
|
|
2000
|
|
1 |
p. 1-
1 p.
|
artikel
|
| 20 |
Editorial Board
|
|
|
2003
|
|
1 |
p. i-
1 p.
|
artikel
|
| 21 |
Editorial Board
|
|
|
1998
|
|
1 |
p. i-
1 p.
|
artikel
|
| 22 |
Editorial Board
|
|
|
2004
|
|
1 |
p. i-
1 p.
|
artikel
|
| 23 |
Editorial Board
|
|
|
2011
|
|
1 |
p. i-
1 p.
|
artikel
|
| 24 |
Editorial for Vol. 6, Issue 1
|
Georgopapadakou, Nafsika
|
|
2003
|
|
1 |
p. v-
1 p.
|
artikel
|
| 25 |
EGF receptor targeting in therapy-resistant human tumors
|
Schmidt, Mathias
|
|
2002
|
|
1 |
p. 11-18
8 p.
|
artikel
|
| 26 |
Eighth conference on DNA topoisomerases and therapy Amsterdam, The Netherlands 15–17 October 1997
|
Giaccone, Giuseppe
|
|
1998
|
|
1 |
p. 73-75
3 p.
|
artikel
|
| 27 |
Emerging new therapies for chemotherapy—resistant cancer using adenoviral vectors
|
Nemunaitis, John
|
|
2002
|
|
1 |
p. 34-46
13 p.
|
artikel
|
| 28 |
Enhanced oncolytic potency of replicative adenovirus expressing p53
|
Nemunaitis, John
|
|
2003
|
|
1 |
p. 5-7
3 p.
|
artikel
|
| 29 |
Erratum
|
|
|
2000
|
|
1 |
p. 66-
1 p.
|
artikel
|
| 30 |
Factors determining cellular mechanisms of resistance to antimitotic drugs
|
Cabral, Fernando
|
|
2001
|
|
1 |
p. 3-8
6 p.
|
artikel
|
| 31 |
Glycolysis as a target for the design of new anti-trypanosome drugs
|
Verlinde, Christophe L.M.J.
|
|
2001
|
|
1 |
p. 50-65
16 p.
|
artikel
|
| 32 |
High-dose chemotherapy: how resistant is breast cancer?
|
Pusztai, Lajos
|
|
1998
|
|
1 |
p. 62-72
11 p.
|
artikel
|
| 33 |
Hypoxic cytotoxic agents: a new approach to cancer chemotherapy
|
Brown, J.Martin
|
|
2000
|
|
1 |
p. 7-13
7 p.
|
artikel
|
| 34 |
Immunotherapy for invasive fungal infections: from bench to bedside
|
Pappas, Peter G.
|
|
2004
|
|
1 |
p. 3-10
8 p.
|
artikel
|
| 35 |
Insights on antibiotic resistance of Staphylococcus aureus from its whole genome: genomic island SCC
|
Ito, Teruyo
|
|
2003
|
|
1 |
p. 41-52
12 p.
|
artikel
|
| 36 |
Interplay between SIRT proteins and tumour suppressor transcription factors in chemotherapeutic resistance of cancer
|
Olmos, Yolanda
|
|
2011
|
|
1 |
p. 35-44
10 p.
|
artikel
|
| 37 |
Lethal mutagens: broad-spectrum antivirals with limited potential for development of resistance?
|
Freistadt, Marion S.
|
|
2004
|
|
1 |
p. 19-24
6 p.
|
artikel
|
| 38 |
Literature Highlights: recent research in infectious disease drug resistance
|
|
|
2004
|
|
1 |
p. 69-73
5 p.
|
artikel
|
| 39 |
Macrolide resistance
|
Weisblum, Bernard
|
|
1998
|
|
1 |
p. 29-41
13 p.
|
artikel
|
| 40 |
Mechanisms of clinical resistance by HIV-I variants to zidovudine and the paradox of reverse transcriptase sensitivity
|
Arts, Eric J.
|
|
1998
|
|
1 |
p. 21-28
8 p.
|
artikel
|
| 41 |
Mechanisms of fluoroquinolone resistance
|
Hooper, David C.
|
|
1999
|
|
1 |
p. 38-55
18 p.
|
artikel
|
| 42 |
Mechanisms of resistance imatinib (STI571) in preclinical models and in leukemia patients
|
Weisberg, Ellen
|
|
2001
|
|
1 |
p. 22-28
7 p.
|
artikel
|
| 43 |
Mechanisms of resistance to imatinib (STI571) and prospects for combination with conventional chemotherapeutic agents
|
Krystal, Geoffrey W.
|
|
2001
|
|
1 |
p. 16-21
6 p.
|
artikel
|
| 44 |
meetings Calendar
|
|
|
2002
|
|
1 |
p. 58-60
3 p.
|
artikel
|
| 45 |
MEETINGS CALENDAR
|
|
|
2001
|
|
1 |
p. 75-77
3 p.
|
artikel
|
| 46 |
Meetings calendar
|
|
|
1998
|
|
1 |
p. 79-80
2 p.
|
artikel
|
| 47 |
Meetings Calendar
|
|
|
1999
|
|
1 |
p. 73-77
5 p.
|
artikel
|
| 48 |
Meetings Calendar
|
|
|
2000
|
|
1 |
p. 59-65
7 p.
|
artikel
|
| 49 |
Membrane and cell wall targets in Aspergillus fumigatus
|
Beauvais, Anne
|
|
2001
|
|
1 |
p. 38-49
12 p.
|
artikel
|
| 50 |
Mobile elements in the evolution and spread of multiple-drug resistance in staphylococci
|
Firth, Neville
|
|
1998
|
|
1 |
p. 49-58
10 p.
|
artikel
|
| 51 |
Mother-to-child transmission of drug-resistant HIV
|
Kijak, Gustavo H.
|
|
2001
|
|
1 |
p. 29-37
9 p.
|
artikel
|
| 52 |
New frontiers in the treatment of liposarcoma, a therapeutically resistant malignant cohort
|
Hoffman, Aviad
|
|
2011
|
|
1 |
p. 52-66
15 p.
|
artikel
|
| 53 |
NF-κB in cancer—a friend turned foe
|
Ravi, Rajani
|
|
2004
|
|
1 |
p. 53-67
15 p.
|
artikel
|
| 54 |
[No title]
|
Georgopapadakou, Nafsika
|
|
2004
|
|
1 |
p. 1-
1 p.
|
artikel
|
| 55 |
Opportunistic amoebae: challenges in prophylaxis and treatment
|
Schuster, Frederick L.
|
|
2004
|
|
1 |
p. 41-51
11 p.
|
artikel
|
| 56 |
pH and drug resistance in tumors
|
Raghunand, Natarajan
|
|
2000
|
|
1 |
p. 39-47
9 p.
|
artikel
|
| 57 |
Pneumocystis carinii: a fungus resistant to antifungal therapies — mechanisms of action of antipneumocystis drugs
|
Russian, David A.
|
|
1998
|
|
1 |
p. 16-20
5 p.
|
artikel
|
| 58 |
Preventing antimalarial drug resistance through combinations
|
White, N.J.
|
|
1998
|
|
1 |
p. 3-9
7 p.
|
artikel
|
| 59 |
Proposed alternatives for the use of anti-HIV drugs
|
Berkhout, Benjamin
|
|
1999
|
|
1 |
p. 69-70
2 p.
|
artikel
|
| 60 |
Proposed alternatives for the use of anti-HIV drugs: is it appropriate?
|
Coffin, John M.
|
|
1999
|
|
1 |
p. 71-72
2 p.
|
artikel
|
| 61 |
3rd International Conference on Therapies for Viral Hepatitis
|
King, Robert W.
|
|
2000
|
|
1 |
p. 55-57
3 p.
|
artikel
|
| 62 |
Recent progress in the diagnosis of fungal infections in the immunocompromised host
|
Erjavec, Z
|
|
2002
|
|
1 |
p. 3-10
8 p.
|
artikel
|
| 63 |
Resistance to non-nucleoside inhibitors of HIV-1 reverse transcriptase
|
Bacheler, Lee T.
|
|
1999
|
|
1 |
p. 56-67
12 p.
|
artikel
|
| 64 |
Role of angiogenesis in the response to anticancer therapies
|
Teicher, Beverly A.
|
|
1998
|
|
1 |
p. 59-61
3 p.
|
artikel
|
| 65 |
Should resistance to azole antifungals in vitro be interpreted as predicting clinical non-response?
|
Odds, Frank C.
|
|
1998
|
|
1 |
p. 11-15
5 p.
|
artikel
|
| 66 |
Subcellular targeting regulates the function of caspase-activated protein kinases in apoptosis
|
Jakobi, Rolf
|
|
2004
|
|
1 |
p. 11-17
7 p.
|
artikel
|
| 67 |
Targeting hypoxia tolerance in cancer
|
Wouters, Bradly G
|
|
2004
|
|
1 |
p. 25-40
16 p.
|
artikel
|
| 68 |
Targeting tumor cell resistance to apoptosis induction with antisense oligonucleotides: progress and therapeutic potential
|
Olie, Robet.A.
|
|
2001
|
|
1 |
p. 9-15
7 p.
|
artikel
|
| 69 |
Telomerase as a potential anticancer target: growth inhibition and genomic instability
|
Faraoni, Isabella
|
|
2000
|
|
1 |
p. 3-6
4 p.
|
artikel
|
| 70 |
The ABC transporter genes of Plasmodium falciparum and drug resistance
|
Peel, Sheila A.
|
|
2001
|
|
1 |
p. 66-74
9 p.
|
artikel
|
| 71 |
The IGF/IGF-1 receptor signaling pathway as a potential target for cancer therapy
|
Burtscher, Ingo
|
|
1999
|
|
1 |
p. 3-8
6 p.
|
artikel
|
| 72 |
The mechanism of resistance to sulfa drugs in Plasmodium falciparum
|
Triglia, Tony
|
|
1999
|
|
1 |
p. 15-19
5 p.
|
artikel
|
| 73 |
The pH difference between tumor and normal tissue offers a tumor specific target for the treatment of cancer
|
Gerweck, Leo E.
|
|
2000
|
|
1 |
p. 49-50
2 p.
|
artikel
|
| 74 |
The use of cyclin-dependent kinase inhibitors alone or in combination with established cytotoxic drugs in cancer chemotherapy
|
Grant, Steven
|
|
2003
|
|
1 |
p. 15-26
12 p.
|
artikel
|
| 75 |
37th interscience conference on antimicrobial agents and chemotherapy (ICAAC) Toronto, Canada, 28 September–1 October 1997
|
Georgopapadakou, Nafsika H.
|
|
1998
|
|
1 |
p. 76-77
2 p.
|
artikel
|
| 76 |
Tumor p53 status and response to topoisomerase II inhibitors
|
Valkov, Nikola I.
|
|
2003
|
|
1 |
p. 27-39
13 p.
|
artikel
|
| 77 |
Workshop on ABC Transporters and Human Diseases
|
Ambudkar, Suresh V.
|
|
2000
|
|
1 |
p. 51-54
4 p.
|
artikel
|
Tijdschrift beschrijving